E. Attolino et al. / Carbohydrate Research 337 (2002) 991–996
995
Compound 16: syrup, Rf 0.41 (1:1 hexane–EtOAc);
[h]D −37.2° (c 1.1, CHCl3); H NMR (CDCl3): l 1.32,
H-3, H-4, H-3%, and H-4%), 4.28 (d, 1 H, J1%,2% 7.8 Hz,
H-1%), 4.50 (d, 1 H, J1,2 7.0 Hz, H-1), 4.55 (s, 2 H,
benzylic CH2), 4.68 and 4.85 (AB system, 2 H, JA,B 12.0
Hz, benzylic CH2), 5.22 (d, 1 H, J4,5 7.8 Hz, H-5),
7.26–7.42 (m, 10 H, aromatic H). 13C NMR (CDCl3): l
20.5 (MeCO), 26.2, 26.7, 27.4, and 27.6 (2×CMe2),
52.6 (COOMe), 53.4 and 55.8 (2×OMe), 68.6 (C-6%),
71.9 (C-5%), 73.4 (2×benzylic CH2), 71.9, 74.4, 75.2,
76.6, and 76.6 (C-2, C-3, C-4, C-5, and C-4%), 78.7 and
79.3 (C-2% and C-3%), 102.0 (C-1%), 105.0 (C-1), 109.7 and
110.3 (2 CMe2), 127.4–128.3 (aromatic CH), 138.0 and
138.3 (aromatic C), 169.7 and 169.9 (MeCO and C-6).
Anal. Calcd for C37H50O14: C, 61.83; H, 7.01. Found:
C, 61.68; H, 7.16.
1
1.35, 1.38, and 1.42 (4 s, 3 H each, 2×CMe2), 2.10 (s,
3 H, MeCO), 3.31 and 3.35 (2 s, 3 H each, 2×OMe);
3.46 (m, 1 H, H-2%), 3.65–3.70 (m, 2 H, H-6%a, and
H-6%b), 3.85 (m, 1 H, H-5%), 4.13–4.39 (m, 7 H, H-3,
H-3%, H-4, H-4%, H-2, H-1, and H-1%), 4.49 and 4.58 (AB
system, 2 H, JA,B 12.1 Hz, benzylic CH2), 4.80 and 4.88
(AB system, 2 H, JA,B 11.9 Hz, benzylic CH2), 4.80 and
5.40 (AB system, 2 H, JA,B 18.3 Hz, H-6a, and H-6b),
7.24–7.41 (m, 10 H, aromatic H). 13C NMR (CDCl3): l
20.2 (MeCO), 26.0, 26.5, 27.0, and 27.5 (2×CMe2),
53.4 and 55.3 (2×OMe), 68.1 and 68.7 (C-6, and C-6%),
72.1 (C-5%), 72.8 and 73.2 (2×benzylic CH2), 73.4 and
74.9 (C-4, and C-4%), 78.4, 78.8, and 79.0 (C-3, C-2, and
C-3%), 80.8 (C-2%), 101.1 (C-1%), 104.8 (C-1), 109.7 and
110.5 (2×CMe2), 127.4–128.1 (aromatic CH), 137.6
and 137.8 (aromatic C), 169.9 (MeCO), 204.1 (C-5).
Anal. Calcd for C36H48O13: C, 62.78; H, 7.02. Found:
C, 62.60; H, 7.10.
4 - O - (2,6 - Di - O - benzyl - 3,4 - O - isopropylidene-i-
D-
galactopyranosyl)-2,3-O-isopropylidene-aldehydo- -glu-
D
curonic acid dimethyl acetal (10).—A solution of 9 (800
mg, 1.13 mmol) in MeOH (7 mL) was treated with 1 M
methanolic NaOMe (1.5 mL) and stirred at rt for 1 h.
The solution was neutralized with solid CO2 and con-
centrated under diminished pressure. The residue was
poured into water (5 mL) and extracted with CH2Cl2
(3×30 mL). The organic extracts were dried, filtered,
and concentrated to give pure (13C NMR) 10 (750 mg,
quantitative) as a white amorphous solid; Rf 0.21 (7:3
EtOAc–MeOH); mp 65–67 °C; [h]D −3.9° (c 1.0,
Compound 9: white solid foam, Rf 0.25 (7:3 EtOAc–
1
MeOH); mp 86–88 °C; [h]D +4.0° (c 1.0, CHCl3); H
NMR (CD3OD): l 1.34, 1.40, 1.49, and 1.54 (4 s, 3 H
each, 2×CMe2), 2.11 (s, 3 H, MeCO), 3.42 (s, 6 H,
2×OMe); 3.56–4.80 (m, 11 H, pyranose H), 4.86–5.02
(m, 4 H, 2×benzylic CH2), 5.35 (d, 1 H, J4,5 4.4 Hz,
H-5), 7.37–7.43 (m, 10 H, aromatic H). 13C NMR
(CD3OD): l 21.1 (MeCO), 26.6, 27.4, 27.7, and 28.1
(2×CMe2), 54.4 and 56.2 (2×OMe), 70.1 (C-6%), 73.0
(C-5%), 74.3 and 74.3 (2×benzylic CH2), 75.3 (C-4%),
76.0 and 76.0 (C-4, and C-5), 77.3, 78.3, and 79.9 (C-2,
C-3, and C-3%), 80.5 (C-2%), 102.1 (C-1%), 106.5 (C-1),
110.7 and 111.5 (2 CMe2), 128.4–129.3 (aromatic CH),
139.7 and 139.7 (aromatic C), 172.6 (MeCO), 176.2
(C-6). Anal. Calcd for C36H48O14: C, 61.35; H, 6.86.
Found: C, 61.05; H, 6.99.
1
CHCl3); H NMR (CD3OD): l 1.27 and 1.30 (2 s, 3 H
each, CMe2), 1.42 (s, 6 H, CMe2), 3.28 and 3.29 (2 s, 3
H each, 2×OMe); 3.16–3.90 (m, 18 H), 7.22–7.43 (m,
10 H, aromatic H). 13C NMR (CD3OD): l 26.5, 27.1,
27.8, and 28.2 (2×CMe2), 54.2 and 56.4 (2×OMe),
70.0 (C-6%), 73.0 and 74.0 (C-4% and C-5%), 74.3 (2×ben-
zylic CH2), 75.2, 77.1, 77.3, and 78.7 (C-2, C-3, C-4,
and C-5), 80.1 and 80.4 (C-2% and C-3%), 101.5 (C-1%),
106.2 (C-1), 110.8 and 111.8 (2×CMe2), 128.6–129.5
(aromatic CH), 139.2 and 139.5 (aromatic C), 177.9
(C-6). Anal. Calcd for C34H46O13: C, 61.62; H, 7.00.
Found: C, 61.87; H, 7.13.
Methyl 5-O-acetyl-4-O-(2,6-di-O-benzyl-3,4-O-iso-
propylidene - i -
dene-aldehydo-
D
- galactopyranosyl) - 2,3 - O - isopropyli-
D
-glucuronate dimethyl acetal (12).—A
Methyl 4-O-(2,6-di-O-benzyl-3,4-O-isopropylidene-i-
solution of 9 (800 mg, 1.13 mmol) in EtOAc (30 mL)
was treated with an ethereal solution of CH2N2, until
the yellow color persisted. Excess CH2N2 was destroyed
by dropwise addition of glacial AcOH, and then the
slightly acid solution was immediately washed with satd
aq NaHCO3, and extracted with EtOAc (3×30 mL).
The organic phase was dried (MgSO4), filtered, and
concentrated under diminished pressure to give 12 (826
mg) as a crude product. After a chromatography on
silica gel eluting with 1:1 hexane–EtOAc, a pure sample
of 12 (770 mg, 95% yield) was obtained as a syrup, Rf
0.43 (1:1 hexane–EtOAc); [h]D +9.6° (c 1.8, CHCl3);
1H NMR (CDCl3): l 1.28 and 1.32 (2 s, 3 H each,
CMe2), 1.42 (s, 6 H, CMe2), 2.11 (s, 3 H, MeCO), 3.34
(m, 1 H, H-2%), 3.34 and 3.35 (2 s, 3 H each, 2×OMe);
3.62 (s, 3 H, COOMe), 3.66–3.70 (m, 2 H, H-6%a, and
H-6%b), 4.11 (m, 1 H, H-5%), 4.19–4.36 (m, 5 H, H-2,
D-galactopyranosyl)-2,3-O-isopropylidene-aldehydo-D-
glucuronate dimethyl acetal (13).—A solution of 12 (800
mg, 1.11 mmol) was treated as described above for the
preparation of 10, giving in quantitative yield 13 (756
mg) as a crystalline white solid, Rf 0.33 (1:1 hexane–
EtOAc); mp 117 °C (from Et2O–hexane); [h]D +10.1°
1
(c 0.9, CHCl3); H NMR (CDCl3): l 1.32, 1.35, 1.40,
and 1.41 (4 s, 3 H each, 2×CMe2), 3.33 and 3.34 (2 s,
3 H each, 2×OMe), 3.40 (m, 2 H, H-2%, and H-5), 3.70
(s, 3 H, COOMe), 3.67–3.91 (m, 3 H, H-5%, H-6%a, and
H-6%b), 4.07–4.17 and 4.43–4.50 (2 m, 5 H, H-2, H-3,
H-4, H-3%, and H-4%), 4.31 (d, 1 H, J1,2 6.0 Hz, H-1),
4.46 (d, 1 H, J1%,2% 7.8 Hz, H-1%), 4.54 and 4.56 (AB
system, 2 H, JA,B 12.1 Hz, benzylic CH2), 4.75 and 4.90
(AB system, 2 H, JA,B 11.5 Hz, benzylic CH2), 7.23–
7.46 (m, 10 H, aromatic H). 13C NMR (CDCl3): l 26.3,
26.5, 27.3, and 27.8 (2×CMe2), 52.2 (COOMe), 53.4